Cytoprotective cytokine signaling and reperfusion injury

$313,975P01FY2000HLNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

Paper 24720920 Paper 22534620 Paper 22301733 Paper 21572013 Paper 20620703 Paper 19964748 Paper 19963485 Paper 19919989 Paper 19821081 Paper 19433759 Paper 19406912 Paper 18833212 Paper 18632582 Paper 18354189 Paper 18255218 Paper 17720767 Paper 17346873 Paper 17283277 Paper 17266545 Paper 17161265 Paper 17114286 Paper 16983089 Paper 16870193 Paper 16842199 Paper 16785036 Paper 16781728 Paper 16731644 Paper 16675849 Paper 16649187 Paper 16645158 Paper 16496177 Paper 16443675 Paper 16306210 Paper 16284241 Paper 16277979 Paper 16247329 Paper 16223947 Paper 16183729 Paper 16165012 Paper 16110151 Paper 16009788 Paper 15978671 Paper 15927970 Paper 15814435 Paper 15774854 Paper 15693606 Paper 15684686 Paper 15665051 Paper 15586361 Paper 15470614 Paper 15364818 Paper 15320517 Paper 15317682 Paper 15280078 Paper 15273447 Paper 15258177 Paper 15210787 Paper 15169973 Paper 15103750 Paper 14742270 Paper 14734125 Paper 14734124 Paper 14678816 Paper 14561159 Paper 14512306 Paper 14500519 Paper 12952018 Paper 12874181 Paper 12867878 Paper 12703982 Paper 12689859 Paper 12663861 Paper 12663264 Paper 12647814 Paper 12586861 Paper 12388071 Paper 12122446 Paper 12105382 Paper 11985909 Paper 11943726 Paper 11909820 Paper 11812164 Paper 11788410 Paper 11756189 Paper 11748296 Paper 11744011 Paper 11709422 Paper 11600420 Paper 11583979 Paper 11583958 Paper 11489774 Paper 11468173 Paper 11458510 Paper 11457751 Paper 11390487 Paper 11390421 Paper 11331260 Paper 11295695 Paper 11294801 Paper 11238444

Abstract

Project 4 is a new project of HL 42550, whose long-term objective is to delineate the mechanisms that are responsible for the recent observation that pro-inflammatory cytokines that signal through the tumor necrosis factor (TNF) receptors or the gp130 family of receptors confer cytoprotective /anti-apoptotic effects in cardiac myocytes. To this end the immediate specific objectives of Project 4 will be to delineate the mechanisms for the cytoprotective effects of these cytokines in the setting of experimental myocardial ischemia/reperfusion (I/R) injury. Specific Aim 1 will test the hypothesis that reactive oxygen intermediates induced during I/R injury in mice are responsible for provoking cardiac myocyte apoptosis through mitochondrial dysfunction, release of cytochrome c, increased activity of caspases 9 and 3, and DNA degradation. Specific Aim 2 will test the hypothesis that TNF protects against I/R induced myocyte apoptosis by attenuating and/or preventing mitochondrial dysfunction, by examining the effects of I/R injury in transgenic mice with low levels of cardiac restricted over-expression of TNF and knockout mice both TNF receptors. Specific Aim 3 will test the hypothesis that the cytoprotective effects of TNF are mediated by TNF receptor associated factor 2 (TAF2), by examining the effects of I/R injury in transgenic mice with conditional over-expression of a TRAF2 dominant negative construct. Specific Aim 4 will test the hypothesis that activation of the gp130 pathway protects the adult cardiac myocyte against I/R induced apoptosis by attenuating the activity of caspases 9 and 3, and that the cytoprotective effects of the gp130 injury in transgenic mice with cardiac restricted expression of leukemia inhibitory factor and mice with a ventricular restricted knockout of gp130. The above studies will be conducted in a Langerdorff buffer perfusion model of global I/R injury, a closed-chest model of I/R injury, and in isolated murine cardiac myocyte model subjected to hypoxia/reoxygenation. Taken together, these studies will provide definitive new information with regard to the basic mechanisms responsible for the cytoprotective effects of pro- inflammatory cytokines following I/R injury.

View original record on NIH RePORTER →